打开APP
userphoto
未登录

开通VIP,畅享免费电子书等14项超值服

开通VIP
History of Changes for Study: NCT04280705
Primary Outcome Measures:1. Percentage of subjects reporting each severity rating on an 8-point ordinal scale
The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 6) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 7) Not hospitalized, limitation on activities and/or requiring home oxygen; 8) Not hospitalized, no limitations on activities.

[Time Frame: Day 15] Time to recovery
Day of recovery is defined as the first day on which the subject satisfies one of the following three categories from the ordinal scale: 1) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 2) Not hospitalized, limitation on activities and/or requiring home oxygen; 3) Not hospitalized, no limitations on activities.

[Time Frame: Day 1 through Day 29] Secondary Outcome Measures:2. Change from baseline in alanine transaminase (ALT)
Day 1 through Day 29 Change from baseline in alanine transaminase (ALT)
Day 1 through Day 29 3. Change from baseline in aspartate transaminase (AST)
Day 1 through Day 29 Change from baseline in aspartate transaminase (AST)
Day 1 through Day 29 4. Change from baseline in creatinine
Day 1 through Day 29 Change from baseline in creatinine
Day 1 through Day 29 5. Change from baseline in glucose
Day 1 through Day 29 Change from baseline in glucose
Day 1 through Day 29 6. Change from baseline in hemoglobin
Day 1 through Day 29 Change from baseline in hemoglobin
Day 1 through Day 29 7. Change from baseline in platelets
Day 1 through Day 29 Change from baseline in platelets
Day 1 through Day 29 8. Change from baseline in prothrombin time (PT)
Day 1 through Day 29 Change from baseline in prothrombin time (PT)
Day 1 through Day 29 9. Change from baseline in total bilirubin
Day 1 through Day 29 Change from baseline in total bilirubin
Day 1 through Day 29 10. Change from baseline in white blood cell count with differential
Day 1 through Day 29 Change from baseline in white blood cell count (WBC) with differential
Day 1 through Day 29 11. Change in National Early Warning Score (NEWS) from baseline
The NEW score has demonstrated an ability to discriminate patients at risk of poor outcomes. This score is based on 7 clinical parameters (respiration rate, oxygen saturation, any supplemental oxygen, temperature, systolic blood pressure, heart rate, level of consciousness). The NEW Score is being used as an efficacy measure.

[Time Frame: Day 1 through Day 29] Change in National Early Warning Score (NEWS) from baseline
The NEW score has demonstrated an ability to discriminate patients at risk of poor outcomes. This score is based on 7 clinical parameters (respiration rate, oxygen saturation, any supplemental oxygen, temperature, systolic blood pressure, heart rate, level of consciousness). The NEW Score is being used as an efficacy measure.

[Time Frame: Day 1 through Day 29] 12. Clinical status using ordinal scale
The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 6) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 7) Not hospitalized, limitation on activities and/or requiring home oxygen; 8) Not hospitalized, no limitations on activities.

[Time Frame: Day 3 through Day 29] Clinical status using ordinal scale
The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 6) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 7) Not hospitalized, limitation on activities and/or requiring home oxygen; 8) Not hospitalized, no limitations on activities.

[Time Frame: Day 3 through Day 29] 13. Cumulative incidence of Grade 3 and 4 adverse events (AEs)

Grade 3 AEs are defined as events that interrupt usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention. Severe events are usually incapacitating.

Grade 4 AEs are defined as events that are potentially life threatening.



[Time Frame: Day 1 through Day 29] Cumulative incidence of Grade 3 and 4 clinical and/or laboratory adverse events (AEs)

Grade 3 AEs are defined as events that interrupt usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention. Severe events are usually incapacitating.

Grade 4 AEs are defined as events that are potentially life threatening.



[Time Frame: Day 1 through Day 29] 14. Cumulative incidence of serious adverse events (SAEs)
An SAE is defined as an AE or suspected adverse reaction is considered serious is, in the view of either the investigator or the sponsor, if results in death, a life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions, or a congenital anomaly/birth defect.

[Time Frame: Day 1 through Day 29] Cumulative incidence of serious adverse events (SAEs)
An SAE is defined as an AE or suspected adverse reaction is considered serious if, in the view of either the investigator or the sponsor, it results in death, a life-threatening AE, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions, or a congenital anomaly/birth defect.

[Time Frame: Day 1 through Day 29] 15. Discontinuation or temporary suspension of infusions
For any reason.

[Time Frame: Day 1 through Day 29] Discontinuation or temporary suspension of investigational therapeutics
For any reason.

[Time Frame: Day 1 through Day 10] 16. Duration of hospitalization
Measured in days.

[Time Frame: Day 1 through Day 29] Duration of hospitalization
Measured in days.

[Time Frame: Day 1 through Day 29] 17. Duration of new non-invasive ventilation or high flow oxygen use

[Time Frame: Day 1 through Day 29] Duration of new non-invasive ventilation or high flow oxygen use
Measured in days.

[Time Frame: Day 1 through Day 29] 18. Duration of new oxygen use

[Time Frame: Day 1 through Day 29] Duration of new oxygen use
Measured in days.

[Time Frame: Day 1 through Day 29] 19. Duration of new ventilator or extracorporeal membrane oxygenation (ECMO) use

[Time Frame: Day 1 through Day 29] Duration of new ventilator or extracorporeal membrane oxygenation (ECMO) use
Measured in days.

[Time Frame: Day 1 through Day 29] 20. Incidence of new non-invasive ventilation or high flow oxygen use
Day 1 through Day 29 Incidence of new non-invasive ventilation or high flow oxygen use
Day 1 through Day 29 21. Incidence of new oxygen use
Day 1 through Day 29 Incidence of new oxygen use
Day 1 through Day 29 22. Incidence of new ventilator or extracorporeal membrane oxygenation (ECMO) use
Day 1 through Day 29 Incidence of new ventilator or extracorporeal membrane oxygenation (ECMO) use
Day 1 through Day 29 23. Mean change in the ordinal scale
The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 6) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 7) Not hospitalized, limitation on activities and/or requiring home oxygen; 8) Not hospitalized, no limitations on activities.

[Time Frame: Day 1 through Day 29] Mean change in the ordinal scale
The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 6) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 7) Not hospitalized, limitation on activities and/or requiring home oxygen; 8) Not hospitalized, no limitations on activities.

[Time Frame: Day 1 through Day 29] 24. Number of non-invasive ventilation/high flow oxygen free days
Day 1 to Day 29 25. Number of oxygenation free days

[Time Frame: Day 1 to Day 29] Percentage of subjects reporting each severity rating on an 8-point ordinal scale
The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 6) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 7) Not hospitalized, limitation on activities and/or requiring home oxygen; 8) Not hospitalized, no limitations on activities.

[Time Frame: Day 15] 26. Subject 14-day mortality
Date and cause of death (if applicable).

[Time Frame: Day 1 through Day 15] Subject 14-day mortality
Date and cause of death (if applicable).

[Time Frame: Day 1 through Day 15] 27. Subject 28-day mortality
Date and cause of death (if applicable).

[Time Frame: Day 1 through Day 29] Subject 29-day mortality
Date and cause of death (if applicable).

[Time Frame: Day 1 through Day 29] 28. Time to an improvement of one category using an ordinal scale
The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 6) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 7) Not hospitalized, limitation on activities and/or requiring home oxygen; 8) Not hospitalized, no limitations on activities.

[Time Frame: Day 1 through Day 29] Time to an improvement of one category using an ordinal scale
The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 6) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 7) Not hospitalized, limitation on activities and/or requiring home oxygen; 8) Not hospitalized, no limitations on activities.

[Time Frame: Day 1 through Day 29] 29. Time to an improvement of two categories using an ordinal scale
The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 6) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 7) Not hospitalized, limitation on activities and/or requiring home oxygen; 8) Not hospitalized, no limitations on activities.

[Time Frame: Day 1 through Day 29] Time to an improvement of two categories using an ordinal scale
The ordinal scale is an assessment of the clinical status at the first assessment of a given study day. The scale is as follows: 1) Death; 2) Hospitalized, on invasive mechanical ventilation or extracorporeal membrane oxygenation (ECMO); 3) Hospitalized, on non-invasive ventilation or high flow oxygen devices; 4) Hospitalized, requiring supplemental oxygen; 5) Hospitalized, not requiring supplemental oxygen - requiring ongoing medical care (COVID-19 related or otherwise); 6) Hospitalized, not requiring supplemental oxygen - no longer requires ongoing medical care; 7) Not hospitalized, limitation on activities and/or requiring home oxygen; 8) Not hospitalized, no limitations on activities.

[Time Frame: Day 1 through Day 29] 30. Time to discharge or to a National Early Warning Score (NEWS) of The NEW score has demonstrated an ability to discriminate patients at risk of poor outcomes. This score is based on 7 clinical parameters (respiration rate, oxygen saturation, any supplemental oxygen, temperature, systolic blood pressure, heart rate, level of consciousness). The NEW Score is being used as an efficacy measure.

[Time Frame: Day 1 through Day 29] Time to discharge or to a National Early Warning Score (NEWS) of The NEW score has demonstrated an ability to discriminate patients at risk of poor outcomes. This score is based on 7 clinical parameters (respiration rate, oxygen saturation, any supplemental oxygen, temperature, systolic blood pressure, heart rate, level of consciousness). The NEW Score is being used as an efficacy measure.

[Time Frame: Day 1 through Day 29] 31. Ventilator/extracorporeal membrane oxygenation (ECMO) free days
Day 1 through Day 29
本站仅提供存储服务,所有内容均由用户发布,如发现有害或侵权内容,请点击举报
打开APP,阅读全文并永久保存 查看更多类似文章
猜你喜欢
类似文章
Paralyzed patient given free medical care
What is reduced capability (RedCap) NR?
成人肺囊性纤维化加重期间及之后矿物质微量元素水平的变化
英文ICU指南
Calcium and Heart Attack Risk: Ending the Con...
【四六级口试班】作业答案Day 9
更多类似文章 >>
生活服务
热点新闻
分享 收藏 导长图 关注 下载文章
绑定账号成功
后续可登录账号畅享VIP特权!
如果VIP功能使用有故障,
可点击这里联系客服!

联系客服